Study Summary
This trial will compare kids who have a 3D printed heart model before VAD surgery to those who don't, to see if the models improve patient outcomes.
Eligible Conditions
- Congenital Heart Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 5 year
30 day
A change in the clarity of cannula and VAD site demonstration
5 year
Improvement in cardiopulmonary bypass time
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Group B - Control
1 of 2
Group A - 3D models
1 of 2
Active Control
Experimental Treatment
44 Total Participants · 2 Treatment Groups
Primary Treatment: 3D model of heart · No Placebo Group · N/A
Group A - 3D models
Other
Experimental Group · 1 Intervention: 3D model of heart · Intervention Types: OtherGroup B - ControlNoIntervention Group · 1 Intervention: Group B - Control · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 year
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,295 Previous Clinical Trials
1,613,227 Total Patients Enrolled
Kanwal Farooqi, MDPrincipal InvestigatorColumbia University
Eligibility Criteria
Age Any Age · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments